Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The aim of this study was to investigate effects of intracavernous injection of adipose-derived stem cells (ADSCs) on cavernous nerve (CN) regeneration and functional status in a nerve-crush rat model. Thirty Sprague-Dawley male rats were randomly divided into three equal groups: one group underwent sham operation, while two groups underwent bilateral CN crush. Crush-injury group was treated at the time of injury with intracavernous injection of ADSCs, or injured control group with no further intervention. Erectile function was assessed by CN electrostimulation after 3 months. Penile tissue and crushed nerves were collected for histology. Three months after surgery, in the group that underwent bilateral nerve crushing with no further intervention, the functional evaluation showed a lower mean maximal intracavernous pressure (ICP) and maximal ICP per mean arterial pressure (MAP) with CN stimulation than those in the sham group. In the group with an immediate intracavernous injection of ADSCs, the mean maximal ICP and maximal ICP/MAP were significantly higher than those in the injured control group. Histologically, the group with the intracavernous injection of ADSCs had more myelinated axons of CNs and more NADPH-diaphorase-positive nerve fibers than the injured control group but fewer than the sham group. Intracavernous injection of ADSCs treatment had beneficial effects on the smooth muscle/collagen ratio in the corpus cavernosum. These results show that the intracavernous injection of ADSCs to the site of CN-crush injury facilitates nerve regeneration and recovery of erectile function. Our research indicates that penile injection of ADSCs can improve recovery of erectile function in a rat model of neurogenic ED.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497875 | PMC |
| http://dx.doi.org/10.1007/s10571-012-9890-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Amniotic fluid stem cell therapy improves erectile function in a diabetic rat model.
Andrology
September 2025
Department of Urology, Knuppe Molecular Urology Laboratory, School of Medicine, University of California, San Francisco, California, USA.
Background: Current treatments for diabetic erectile dysfunction, such as phosphodiesterase type 5 inhibitors, penile injection, or vacuum erection devices, primarily offer symptomatic relief and do not address the underlying pathophysiology, which involves neural, vascular, and smooth muscle degeneration.
Objectives: This study aimed to evaluate the therapeutic potential of amniotic fluid-derived stem cells in a rat model of diabetic erectile dysfunction by assessing their impact on erectile function and penile tissue regeneration.
Methods: Male Sprague‒Dawley rats were divided into control, diabetic, and amniotic fluid-derived stem cell-treated diabetic groups.
[Hypoandrogenism and the mode of cell death in the penile cavernosum tissue of male rats].
Zhonghua Nan Ke Xue
April 2025
Department of Urology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
Objective: To study the mode of cell death in the penile cavernosum tissue of male rats in the hypoandrogenic state.
Methods: We equally randomized 36 10-week-old SD male rats into six groups: 4-week sham-operation (4-wk SO), 8-week sham-operation (8-wk SO), 4-week castration (4-wk C), 8-week castration (8-wk C), 4-week castration + testosterone replacement (4-wk C+T), and 8-week castration + T replacement (8-wk C+T). The rats in the SO groups received incision of the scrotal skin with preservation of the testis and epididymis, those in the C groups underwent bilateral orchiectomy and epididymectomy, and those in the C+T groups were subcutaneously injected with T propionate at 3 mg/kg qd alt.
Intracavernous Self-injection of Papaverine Plus Chlorpromazine (Bimix) for the Treatment of Erectile Dysfunction.
Niger Postgrad Med J
July 2025
Department of Surgery, Urology Unit, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria.
Background: Erectile dysfunction (ED) affects the physical and psychological health of a patient and his partner and can have a significant negative impact on their quality of life. Second-line therapies for ED include intracavernosal injections of vasoactive drug (ICIVAD) among others.
Aims: The aim of this study was to assess the efficacy of combination of papaverine and chlorpromazine (bimix) for the treatment of ED in patients who are unresponsive to 5-Phosphodiestrase inhibitors (PDE5-I).
A novel autologous material for the surgical treatment of Peyronie's disease: the outer plate of the prepuce.
Transl Androl Urol
June 2025
Department of Urology Surgery, Ningbo Urology and Nephrology Hospital, Ningbo Yinzhou No. 2 Hospital, Ningbo, China.
Background: Peyronie's disease (PD), a connective tissue disease, is characterized by the formation of fibrous lesions or plaques in the tunica albuginea. Many PD patients rely on surgical treatment methods. This study aimed to investigate the feasibility of using the outer plate of the prepuce to repair the defect of the corpus cavernosum after plaque enucleation in patients with PD.
View Article and Find Full Text PDFErectile dysfunction: A public health issue? The need for consistent treatment.
Vasc Dis (Paris)
August 2025
Center for Exploration and Treatment of Impotence (CETI), Paris, France. Electronic address:
Erectile dysfunction (ED), like any pathology, merits diagnostic evaluation prior to treatment. Listening, accompanied by validated questionnaires, Doppler ultrasound under pharmacological erectile stimulation and testosterone levels are the basic elements. These are complemented by nerve tract examinations, angiography and/or cavernoscans.
View Article and Find Full Text PDF